Faculty profile

Jean Roy

ResearcherMedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Jean Roy

Researcher

Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
15 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2014.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

473

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cord Blood Transplantation Fed Batch Culture System Hematopoietic Stem Cell Expansion Novel Agonist Of Stem Cell Renewal Phase I Clinical Study

Latest papers

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.
Case reports in hematology · 2026
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.
Bone marrow transplantation · 2026 · senior author
Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity.
Haematologica · 2026

All 30 publications

Latest funding

Clinical application of a novel molecule that expands human cord blood stem cells
CIHR · 2014 · Nominated PI
$1,013,167
A Randomized Trial of Thymoglobulin to Prevent Chronic Graft versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation from Unrelated Donors
CIHR · 2009 · Co-investigator
$1,245,055

All 2 grants and awards

30 publications.

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

Larin É, Busque L, Chabot-Roy G, Lesage S, Jadot G, LeBlanc R, Roy J, Claveau JS, Szuber N

Case reports in hematology2026

DOI: 10.1155/crh/7405586 PMID: 42630736

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

Thiant S, Dufresne S, Ahmad I, Cohen S, Delisle JS, Fernandez-Vargas OE, Kiss T, Lachance S, Roy DC, Veilleux O, Bernard L, Gisela Rodriguez D, Sauvageau G, Roy J

Bone marrow transplantation2026Senior author

DOI: 10.1038/s41409-026-02902-4 PMID: 42265463

Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity.

Jadot G, Sabouret A, Couture A, Laflamme L, Larose F, Ahmad I, Benkirane K, Delisle JS, Fleury I, Lachance S, LeBlanc R, Roy J, Thiant S, Veilleux O, Claveau JS

Haematologica2026

DOI: 10.3324/haematol.2025.289122 PMID: 41885028

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study.

Laurin A, Rousseaux F, Fournier V, Roy J, Landry M, LeBlanc R, Godin N, Arbour C, Richebé P, Jerbi K, Rainville P, Ogez D

PloS one2026

DOI: 10.1371/journal.pone.0338617 PMID: 41758815

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Schweitzer L, Thiant S, Thérien C, Giroux M, Lachance S, Fleury I, Orio J, Carli C, Boudreau G, Patenaude J, Tremblay-Laganière C, Senécal L, Dufresne SF, Mollica L, Collette S, Sauvageau G, Kiss T, Cohen S, Bernard L, Bambace N, Veilleux O, Ahmad I, Roy J, Busque L, Duval M, Bittencourt H, Teira P, Lamarche C, Roy DC, Delisle JS

Open forum infectious diseases2026

DOI: 10.1093/ofid/ofag006 PMID: 41614086

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Cohen S, Labopin M, Bambace N, Ahmad I, Dumont-Lagacé M, Ciceri F, McLornan DP, Labussière-Wallet H, Kröger N, de Latour RP, Chalandon Y, Forcade E, Cluzeau T, Jindra P, Kulagin A, Roy J, Lachance S, Barabé F, Caudrelier P, Sauvageau G, Yakoub-Agha I, Mohty M

Transplantation and cellular therapy2025

DOI: 10.1016/j.jtct.2025.08.006 PMID: 40818826

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

Tanguay M, Cohen S, Ménard I, Meunier MC, Delisle JS, Roy J, Veilleux O, Ahmad I

Hematology (Amsterdam, Netherlands)2025

DOI: 10.1080/16078454.2024.2448552 PMID: 39763113

A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients.

Roy J, Cohen S, Sauvageau G, Ahmad I, Fournier V, Terra R, Caudrelier P, Thiant S, Thauvette G, Bambace N, Delisle JS, Lachance S, Kiss T, Bernard L, Roy DC, Veilleux O, LeBlanc R

Transplantation and cellular therapy2025First author

DOI: 10.1016/j.jtct.2024.10.008 PMID: 39419177

Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia.

Tessier C, LeBlanc R, Roy J, Trudel S, Côté J, Lalancette M, Boudreault JS, Lemieux-Blanchard É, Kaedbey R, Pavic M

Cancer medicine2024

DOI: 10.1002/cam4.70192 PMID: 39225552

Assessment of h-index and associated demographic and academic parameters for academic hematologists in Canada.

Ordaz DJG, Roy J, Ahmad I, Kaouache M, Ramchatesingh B, Whitelaw S, Nikonova A, Bredeson C, Litvinov IV

Frontiers in medicine2024

DOI: 10.3389/fmed.2024.1457366 PMID: 39281820

Something wrong or missing on this profile? Suggest a correction

Jean Roy

Research

Latest papers

Latest funding

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity.

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study.

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients.

Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia.

Assessment of h-index and associated demographic and academic parameters for academic hematologists in Canada.

Clinical application of a novel molecule that expands human cord blood stem cells

A Randomized Trial of Thymoglobulin to Prevent Chronic Graft versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation from Unrelated Donors

Frequent collaborators

Guy Sauvageau

Sandra Cohen

Lambert Busque

Denis-Claude Roy

Claude Perreault

Tony Panzarella

Sylvie Lesage

John Kuruvilla

David Ogez

Ronan Foley

Irwin Ronald Walker

Mathieu Landry

Pierre Thibault

Julia Cadrin-Tourigny

Caroline Lamarche

Anne Marinier

Caroline Arbour

Francis Rodier

Michael Sebag

Pierre Rainville